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Rationale: IgE antibodies to themammalian oligosaccharide galactose-
a-1,3-galactose (a-gal) are common in the southeastern United States.
These antibodies, which are induced by ectoparasitic ticks, can give
rise to positive skin tests or serum assays with cat extract.
Objectives: To evaluate the relationship between IgE antibodies to
a-gal and asthma, and compare this with the relationship between
asthma and IgE antibodies to Fel d 1 and other protein allergens.
Methods: Patients being investigated for recurrent anaphylaxis,
angioedema,oracuteurticariaunderwentspirometry, exhalednitric
oxide, questionnaires, and serum IgE antibody assays. The results
were compared with control subjects and cohorts from the emer-
gency department in Virginia (n ¼ 130), northern Sweden (n ¼
963), and rural Kenya (n ¼ 131).
Measurements andMainResults: Patients inVirginiawithhigh-titer IgE
antibodies to a-gal had normal lung function, low levels of exhaled
nitric oxide, and low prevalence of asthma symptoms. Among
patients in the emergency department and children in Kenya, there
was no association between IgE antibodies to a-gal and asthma
(odds ratios, 1.04 and 0.75, respectively). In Sweden, IgE antibodies
to catwere closely correlatedwith IgE antibodies to Fel d 1 (r¼ 0.83)
and to asthma (P, 0.001).
Conclusions: These results provide a model of an ectoparasite-
induced specific IgE response that can increase total serum IgEwith-
out creating a risk for asthma, and further evidence that the main
allergens that are causally related to asthma are those that are inhaled.
Keywords: a-gal; red meat allergy; ticks; total serum IgE; ectoparasite
A large proportion of children and young adults with asthma
have serum IgE antibodies specific to one or more common in-
halant allergens, and in Western countries elevated total serum
IgE (1–5). Furthermore, it is possible to make a logical argu-
ment that inhaling allergens into the lungs of a subject who is
allergic is a major cause of asthma (6, 7). However, questions
about the evidence for a causal relationship between allergen
exposure and asthma have come from studies of different types
(8–10). These included an influential paper from Arizona that
reported a strong correlation between total IgE and asthma, but
no correlation between asthma and specific sensitization (10).
That finding was used to argue that IgE production was a non-
specific response to inflammation in the lungs (11). Our view
has been that inhalation of allergens by subjects who are allergic
is causally related to asthma, and that the specific IgE antibod-
ies that are important in relation to asthma can make a signifi-
cant contribution to total IgE (12). However, in rural areas of
developing countries where asthma is rare, most children have
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AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
There are still questions about the importance of specific
and total IgE in the pathophysiology of asthma in Western
countries, and also about how children in developing countries
can have high total serum IgE with no relationship to allergic
disease. The recent finding of IgEantibodies to themammalian
oligosaccharide galactose-a-1,3-galactose makes it possible to
study the clinical relevance of a parasite-induced IgE response
within a Western country.
What This Study Adds to the Field
We show that the presence of IgE antibodies to galactose-
a-1,3-galactose have no influence on the risk of asthma
even though they cross-react with glycosylation on cat
proteins and can make major contributions to total IgE.
This is in direct contrast to IgE antibodies to protein
allergens, such as Fel d 1, which are airborne in houses and
strongly associated with asthma.
elevated levels of total IgE, often as high as 1,000 IU/ml (1 IU ¼
2.4 ng) with no associated allergic symptoms or relationship to
asthma (13–15).
Recently, we have identified a novel IgE antibody response to
a mammalian oligosaccharide epitope, galactose-a-1,3-galactose
(a-gal) (16). The presence of these a-gal–specific IgE antibodies,
which are predominantly found in people living in the southeastern
United States, has been associated with two forms of anaphylaxis:
immediate-onset anaphylaxis during first exposure to intravenous
cetuximab; and delayed-onset anaphylaxis after ingestion of mam-
malian food products (e.g., beef and pork) (16, 17). Furthermore,
we have recently published evidence that IgE antibodies to a-gal
are induced by tick bites, predominantly those of the Lone Star
tick (Amblyomma americanum) (18).
The oligosaccharide a-gal is present on proteins derived
from all nonprimate mammals, including cat and dog proteins
(19). In keeping with that, most of the patients with IgE to
a-gal give positive intradermal skin tests and positive serum
IgE antibodies to cat and dog allergens (16, 17, 20). Our pre-
liminary experience in the clinic suggested that this IgE anti-
body response was not related to asthma. Thus, we have the
enigma of patients who seem to be allergic to cat and dog, but
in general do not report symptoms around animals and do not
seem to have an increased risk of asthma. In addition, we have
identified two cohorts (one from the University of Virginia
emergency department (ED), the other from Kabati, Kenya)
in which there was a previously unexplained predominance of
IgE antibodies to cat. We report here a detailed investigation
of the relevance of IgE antibodies to a-gal, not only in the
United States, but also in northern Sweden and rural Kenya
(13, 21). The results provide direct evidence for an IgE anti-
body response that can increase total serum IgE but is unre-
lated to inhalant allergic symptoms or asthma. Some of the
results of these studies have been previously reported in the
form of abstracts (22, 23).
METHODS
Study Subjects and Populations for Comparison
Subjects over the age of 10 years presenting to allergic disease clinics
in central Virginia were enrolled into one of three arms. Patients
presenting with a primary complaint of otherwise idiopathic, recur-
rent acute urticaria, angioedema, or anaphylaxis were enrolled into
the “anaphylaxis–urticaria” group (n ¼ 208) regardless of whether
their history was suspicious for delayed anaphylaxis to red meat (17).
Subjects presenting to clinic with asthma, regardless of whether they
may also have had symptoms of urticaria, angioedema, or anaphy-
laxis, were enrolled into the “asthma” group (n ¼ 68). Subjects in the
“clinic control” group (n ¼ 59) represent patients seeking care for
any other complaint; note that this group is not expected to repre-
sent a truly random control group. “Random control subjects” (n ¼
217) were enrolled from three southeastern states (see the online
supplement). After obtaining written informed consent, subjects
responded to a questionnaire (see Form I in the online supplement).
Sera collected were analyzed for a-gal–specific IgE and total IgE. A
random selection of 78 a-gal–positive anaphylaxis–urticaria subjects
underwent additional tests: spirometry, exhaled nitric oxide (eNO),
and complete blood count. Approval for these studies was obtained
locally in the area where subjects were enrolled and from the Uni-
versity of Virginia Human Investigation Committee.
Asthma exacerbations and other emergency department control subjects.
Serum collected for a previous study of 130 subjects older than age 18
years presenting to the ED at the University of Virginia between 1998
and 1999 (60 with acute asthma exacerbations, 70 with any other com-
plaint) were analyzed for total serum IgE and IgE specific to a-gal, dust
mite, cockroach, cat epithelium, and Fel d 1. The eNO, sinus CT, and
inflammatory marker results of that study have previously been re-
ported (24, 25).
Assessment of subjects from geographically diverse areas. As part of
a prospective study on asthma in northern Sweden, sera were obtained
from 963 subjects at age 18 years (21, 26). Those sera with positive
assays for IgE antibodies to cat epithelium and dander of class 2 or
higher (i.e., .0.70 IU/ml; n ¼ 148) were assayed for IgE to a-gal and
Fel d 1. Similarly, IgE titers to cat epithelium, a-gal, and Fel d 1 were
measured using banked serum from our previous study of 131 school-
children (mean age, 11.5 years) living in Kabati, Kenya (13). Details on
these cohorts are available online.
ImmunoCAP IgE Assays and Absorption Experiments
Total and specific IgE antibodies were measured by using either com-
mercially available ImmunoCAP (Phadia US, Portage, MI) or a modi-
fication of the assay with streptavidin on the solid phase (27).
Absorption assays were performed with a-gal or bovine thyroglobulin
bound to sepharose beads using methods as previously published and
as detailed in the online supplement (16, 17).
Figure 1. Galactose-a-1,3-galactose (a-Gal)–
specific IgE antibody titers. Numbers in gray de-
note the number of subjects in each group with
no detectable IgE antibodies to a-gal. Note that
a-gal IgE titers are sometimes markedly ele-
vated. IgE titers do not differ between subjects
living with or without cats. Prevalence of IgE
antibodies to a-gal was significantly higher
(P , 0.001) among patients with anaphylaxis,
angioedema, or acute urticaria, and the mean
IgE antibody titer among positives was signifi-
cantly higher than among the random control
subjects (P , 0.001). Bars represent the geo-
metric mean of the positive values for each
group.
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Airborne Sample Collection and
Inhibition Radioimmunoassay
Samples were collected using Ionic Breeze Quadra (The Sharper Image,
New York, NY) and quantified using an inhibition radioimmunoassay
specific for the a-gal epitope (28, 29). The details of both procedures
are available online.
Statistical Analyses
Statistical analyses were performed with SPSS software, version 18.0
(SPSS Inc., Chicago, IL), and GraphPad Prism, version 4 (GraphPad
Software, La Jolla, CA).
RESULTS
IgE Responses to a-Gal in Virginia Are Associated with
Anaphylaxis and Can Contribute to Total Serum IgE but
Do Not Create an Increased Risk for Asthma
Of 208 patients who presented to allergy clinics in central Vir-
ginia for evaluation of apparently idiopathic anaphylaxis,
angioedema, or repeated episodes of severe urticaria, 187 were
found to have serum IgE antibodies to a-gal (Figure 1, Table
1). Furthermore, the titer of a-gal–specific IgE was signifi-
cantly higher among those in the anaphylaxis–urticaria group
compared with random control subjects with IgE antibodies to
a-gal (geometric mean 16.5 vs. 3.7 IU/ml, respectively; P ,
0.001). The prevalence of a positive test for a-gal (i.e., a-gal–
specific IgE >0.35 IU/ml) among subjects in the random con-
trol group was only 19%, compared with 89% positive in the
anaphylaxis–urticaria group. The anaphylaxis–urticaria group
was also tested for total IgE, and there was a clear correlation
between IgE to a-gal and total IgE (r ¼ 0.60; P , 0.001)
(Figure 2). In many cases, the IgE antibodies to this oligosac-
charide seemed to represent greater than 10% of the total se-
rum IgE, and in some cases greater than 30% of the total. This
was true even in sera with total IgE more than 1,000 IU/ml
(Figure 2). To confirm that a-gal–specific IgE antibodies were
directly contributing to elevated total IgE, absorption studies
were performed on eight sera, which showed that removing IgE
antibodies to a-gal removed an equal quantity of total IgE (Ta-
ble 2). The results confirm that the unit used here for IgE anti-
bodies is quantitatively the same as the unit used for total IgE.
In keeping with our previous results, greater than 90% of the
a-gal–positive sera also gave positive results for IgE to cat and
dog allergens (17).
In questionnaires, only a minority (13%) of subjects in the
anaphylaxis–urticaria group with IgE to a-gal had received
a diagnosis of asthma from a physician at some point in their
life. Spirometry, eNO, and peripheral blood eosinophil counts
were obtained in 78 subjects who were randomly selected
from the anaphylaxis–urticaria group; all 78 had IgE antibod-
ies to a-gal, 43 were living in a house with a cat, 46 had an
a-gal–specific IgE titer greater than or equal to 10 IU/ml, and
11 (14%) had been diagnosed with asthma by a physician
(Figures 3A and 3B, Table 3). These results show that these
patients do not have a prevalence of asthma greater than that
of the general population, and also that neither lung function
nor eNO were influenced by living with an animal. Even when
those subjects with a-gal titers greater than 10 IU/ml were
considered separately, objective measures of asthma includ-
ing eNO, FEV1, and FEV1/FVC are no different from those
with a-gal titers less than 10 IU/ml (Table 3). Likewise, those
with high-titer IgE to a-gal were no more likely to have
physician-diagnosed asthma (x2 ¼ 0.52; P ¼ 0.47) or require
daily asthma medication (x2 ¼ 0.38; P ¼ 0.54). The rate of
sensitization to common nonmammalian inhalant allergens
(e.g., timothy grass, Alternaria, and so forth) among anaphy-
laxis–urticaria subjects with IgE to a-gal was no higher than
that of the general population (see Table E1 in the online
supplement).





SubjectsCat* No cat Asthma
Number enrolled 96 112 68 59
a-Gal positive, n 88 99 10 4
Age range 10–77 9–83 20–74 19–74
Percent male 52% 34% 45% 38%
Physician-diagnosed asthma (%) 10 (10) 22 (20) 68 (100) 7 (12)
Total serum IgE, IU/ml† 164‡ 190‡ 166x 28k
Definition of abbreviation: a-gal ¼ galactose-a-1,3-galactose.
*Anaphylaxis–urticaria subjects living with a cat in the home.
yGeometric mean.
zNo significant difference between those living with a cat or not.
xNo significant difference between the asthma group and anaphylaxis group.
kP , 0.001 compared with anaphylaxis group or asthma group.
Figure 2. Total serum IgE correlates with the titer of IgE
specific for galactose-a-1,3-galactose(a-gal) among the
anaphylaxis–urticaria group. Those subjects whose a-gal–
specific IgE antibodies make up at least 10% (or 30%) of
their total serum IgE fall on or above the green (or blue)
line.
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IgE Antibodies to Fel d 1 but Not to a-Gal Correlate with
Acute Asthma among Patients Presenting to an ED
Subjects presenting to the University of Virginia ED with acute
asthma (n ¼ 60) or any other complaint (n ¼ 70) were found to
have IgE antibodies to cat epithelium that were only weakly
associated with asthma (odds ratio [OR], 2.15; 95% confidence
interval [CI], 0.98–4.75; P ¼ 0.08). The sera from that study
have now been assayed for IgE antibodies to the major cat
allergen Fel d 1, and to a-gal. The results show that IgE anti-
bodies to Fel d 1 were significantly associated with asthma (OR,
4.7; 95% CI, 1.6–13.8; P ¼ 0.005), whereas IgE antibodies to
a-gal showed no association (OR, 1.04; 95% CI, 0.43–2.54; P ¼
0.93) (Table 4). The findings for cat allergen are explained by
the fact that the solid phase used for the IgE assay for cat
epithelium contained Fel d 1 and proteins glycosylated with
a-gal. In the ED study, having IgE antibodies (.0.35 IU/ml)
to any one of three indoor allergens (dust mite, cockroach, or
Fel d 1) was only modestly associated with asthma (OR, 1.6;
95% CI, 0.81–3.2; P ¼ 0.18); high-titer antibodies (>10 IU/ml)
to one or more of the three indoor allergens carried a highly
significant risk for asthma (OR, 3.5; 95% CI, 1.48–8.2; P ¼
0.0004) (Table 4).
Studies in Cohorts with or without Endemic Helminth or
Ectoparasite Infection Reveal Geographic Disparities in the
Relationship between IgE Antibodies to Cat and IgE
Antibodies to Fel d 1
To further examine the contrast between IgE antibodies to
a carbohydrate epitope and IgE to a protein allergen, such
as Fel d 1, we compared results from a rural area of Kenya
where parasites are ubiquitous with those from Norrbotten,
Sweden, an area in the north of Sweden where helminths
and ectoparasites are uncommon (13, 21, 26, 30). The results
show dramatically different patterns of sensitization to cat-
related allergens for the two regions (Figure 4). In northern
Sweden, IgE antibodies to cat correlated quantitatively with
IgE antibodies to Fel d 1 (r ¼ 0.83; P , 0.001) (Figures 4A and
4C). Moreover, the quantity of IgE antibodies to Fel d 1
showed a highly significant direct relationship to asthma as
judged by symptoms or medication use (x2 test for trend ¼
82, P , 0.001, and x2 ¼ 67, P , 0.001, respectively). The sera
from Kenya also had a high prevalence of IgE antibodies to cat
allergens; however, it is now clear that these cat antibodies are
largely explained by IgE responses to a-gal, rather than Fel d 1
(Figures 4B and 4D) (17, 18). Questionnaire data regarding
baseline asthma symptoms and also changes in FEV1 after a
6-minute exercise challenge were collected on the Kenyan
children. These data were compared with cat-specific IgE,
Fel d 1–specific IgE, and a-gal–specific IgE (see Table E2).
The ORs comparing a-gal IgE titers with exercise-induced bron-
chospasm, or symptoms or medication requirements, were 0.40
(95% CI, 0.14–1.20) and 0.75 (95% CI, 0.12–4.67), respectively.
a-Gal Is Not Airborne in Homes
It is well established that Fel d 1 is airborne in homes with a cat,
and estimates of daily exposure range as high as 1 mg (28, 29).
Using a sensitive radioimmunoassay for a-gal, we assayed this
antigen in samples obtained from homes with or without cats
or dogs (17). The a-gal epitope was not detectable in airborne
samples from these homes (Table 5). As expected, Fel d 1 and
Can f 1 were present in significant quantities in the same
samples.
DISCUSSION
The results presented here provide extensive evidence that
a specific IgE antibody response to an oligosaccharide common
to all nonprimate mammals does not create a risk for asthma.
Through examination of patients in Virginia with IgE to a-gal,
patients presenting with asthma to the ED in Charlottesville,
or children in a Kenyan village, it is clear that having this
antibody is not related to lung inflammation or symptoms.
Given that sensitization to cat allergens has been consistently
associated with asthma, it was a surprise to find a large number
of patients presenting with recurrent anaphylaxis or urticaria
who had positive skin tests and serum assays to cat. As judged
by symptoms, eNO, and lung function, few of these patients
had asthma. This conclusion was supported by further investi-
gation of two cohorts in which we had previously noticed a high
prevalence of IgE antibodies to cat but no increased risk for
asthma: the Charlottesville ED and Kenyan school children
(13, 25). In each case, the apparently anomalous results for
cat were explained by the finding of IgE antibodies to the
oligosaccharide a-gal.
Allergens including house dust mite (Der p 1) and cat
(Fel d 1) that clearly correlate with risk for asthma are proteins
with a complex surface and multiple epitopes that favor binding
of high-affinity IgE antibodies (31, 32); such protein allergens
are able to induce positive skin tests with concentrations of
purified proteins in the range of 1023 to 1025 mg/ml. In con-
trast, our own experience and a recent study reported positive
skin tests in patients with IgE to a-gal using 5–50 mg/ml of





IgE Values IgE Values Difference IgE Values Difference
Serum No. a-Gal Total a-Gal Total a-Gal Total a-Gal Total a-Gal Total
E333 7.05 14.5 ,0.35 6.28 6.70 8.22 0.92 7.11 6.13 7.39
E340 6.71 23.7 ,0.35 21.5 7.54 8.40 ND ND ND ND
E361 44.3 357 0.37 292 42.5 37 ND ND ND ND
E368 28.6 146 3.85 126 24.8 20 3.49 131 25.1 15
E377 4.72 77.4 ,0.35 69.5 4.37 7.90 0.63 71.1 4.09 6.30
E384 43.9 124 2.37 75.8 41.5 48.2 4.53 83.1 39.4 40.9
T405 434 1,050 7.02 612 427 438 40.9 666 394 384
T454 1.27 21.9 ,0.35 18.3 0.85 0.90 ND ND ND ND
Definition of abbreviations: a-gal ¼ galactose-a-1,3-galactose; ND ¼ not done.
The similar postabsorption values, reported both in absolute values and as the decrease in a-gal–specific or total IgE
(IU/ml), confirm that specific IgE responses represent a large proportion of the total.
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cetuximab (33). The blunted skin test response using this
mammalian oligosaccharide is consistent with responses to
skin testing in patients with IgE antibodies to plant oligosaccha-
rides (34, 35). Given the small quantities of protein that actually
enter the large and medium airways, it makes sense that an al-
lergen that requires micrograms to produce a positive skin test
would not give rise to inflammation in the lungs. The evidence
reported here for the association between IgE antibodies to
Fel d 1 and asthma in northern Sweden is in keeping with a model
where allergen entering the lungs of a sensitized subject is able to
cross-link IgE receptors on mast cells and trigger inflammation
in the lungs. The role of Fel d 1 in asthma may also involve T-cell
epitope-mediated recruitment of T cells that contribute to the
pathogenesis of lung inflammation (36–38). With regard to
a-gal, the specificity of the T cells associated with this potential
mechanism is not known. However, exposure to this epitope
either as a food or inhalant is unlikely to occur on the same
carrier as was involved in the initial tick-induced IgE antibody
response. The lack of a relevant carrier could also contribute to
the absence of a pulmonary response in these patients.
It has been consistently reported that total serum IgE is el-
evated among patients with asthma, but mixed opinions about
the significance of this observation persist (5, 10–12). The IgE
antibody response to a-gal may provide further insight in that
it not only correlates strongly with total serum IgE, but also
that this IgE response can represent a large proportion of the
total IgE. In addition, we have documented specific IgE to
a-gal and total IgE rising in parallel after tick bites (18).
Although it is well recognized that helminth infection can
induce IgE antibodies, only limited studies on the specificity
of these IgE antibodies or the quantitative contribution of these
antibodies to total serum IgE have been reported (39). As with
other immunoglobulin isotypes and with other IgE responses, the
specific IgE responses do not explain the total (40). The impor-
tant conclusion here is that this IgE antibody response to an
oligosaccharide epitope is a “cause” of elevated total IgE in the
United States and is nonetheless unrelated to asthma.
The results here explain the previously enigmatic finding of
IgE antibodies to cat in Kenya and South Africa (13, 15).
Several studies in Africa have reported the presence of sensiti-
zation to mite allergens that was not related to asthma (13–15,
41). However, those IgE antibody responses, where measured,
were low in titer (13, 15, 41). Recently, we have reported that
a major effect of affluence among school children in Kumasi,
Ghana, was increased titer of IgE antibodies to mite (41). The
evidence reported here about the influence of high-titer IgE
Figure 3. Objective measures of asthma support our clinical observation that galactose-a-1,3-galactose(a-gal)–positive anaphylaxis–urticaria sub-
jects are no more likely to have asthma than the clinic control group, and that living with cats has no impact. Arithmetic means with standard
deviation are displayed. (A) Exhaled nitric oxide among a-gal–positive anaphylaxis–urticaria subjects is significantly lower than that of the asthma
group and no different from the clinic control group. (B) The ratio of FEV1 to FVC among a-gal–positive anaphylaxis–urticaria subjects is significantly
higher than the asthma group and no different from the clinic control group.
TABLE 3. SPIROMETRY, EXHALED NITRIC OXIDE, AND PERIPHERAL EOSINOPHIL COUNT
a-Gal–Positive Anaphylaxis–Urticaria Subjects
Asthma Clinic Control SubjectsTotal Cat No Cat a-Gal IgE >10 IU/ml*
Number 78 43 35 46 68 41
Physician-diagnosed asthma (%) 11 (14) 6 (14) 5 (14) 4 (9) 68 (100) 5 (12)
FEV1 to FVC ratio 0.79 (0.77–0.81) 0.80 (0.78–0.82) 0.79 (0.77–0.81) 0.79 (0.76–0.82) 0.70 (0.68–0.73)
† 0.80 (0.78–0.83)
% predicted FEV1 91 (88–94) 91 (88–95) 92 (87–97) 92 (87–97) 74 (69–79)
† 95 (91–99)
Exhaled NO, ppb 23 (19–28) 18 (15–20) 24 (17–31) 20 (16–24) 51 (38–64)† 20 (13–27)
Eosinophils per ml 209 (167–251) 205 (166–243) 213 (165–260) 192 (160–223) 352 (280–424)‡ 183 (107–260)
Definition of abbreviations: a-gal ¼ galactose-a-1,3-galactose; NO ¼ nitric oxide; ppb ¼ parts per billion.
Values are the arithmetic mean followed by the 95% confidence interval in parentheses.
*Subjects with IgE antibody titers to a-gal greater than or equal to 10 IU/ml.
yP , 0.001 compared with a-gal–positive group or clinic control group.
zP , 0.01 compared with a-gal–positive group or clinic control group.
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antibody on asthma in Virginia and Sweden may help to explain
the finding that low-level sensitization to mite in developing coun-
tries shows little relationship to allergic symptoms or asthma.
In a recent publication, we reported that the IgE antibody
response to a-gal is primarily induced by tick bites, specifi-
cally those of the species A. americanum (the Lone Star tick)
TABLE 4. IGE ANTIBODIES TO a-GAL, FEL D 1, AND INDOOR ALLERGENS AMONG SUBJECTS
(AGE 18–50) PRESENTING TO AN EMERGENCY DEPARTMENT IN VIRGINIA
All ED Subjects Asthma ED Subjects Control ED Subjects Odds Ratio
Number enrolled 130 60 70
IgE to a-gal (IU/ml)
.0.35 24 12 12 1.04 (0.43–2.5); P ¼ 0.93
.3.5 7 3 4 0.76 (0.16–3.6); P ¼ 0.73
.10 4 1 3 0.33 (0.03–3.3); P ¼ 0.35
IgE to Fel d 1 (IU/ml)
.0.35 22 17 5 4.7 (1.6–13.8); P ¼ 0.005
.3.5 8 7 1 8.4 (0.99–70); P ¼ 0.05
.10 5 5 0
IgE to indoor allergens: dust mite, cockroach, or Fel d 1 (IU/ml)
.0.35 60 41 29 1.6 (0.81–3.2); P ¼ 0.18
.3.5 46 32 14 2.9 (1.4–6.2); P ¼ 0.006
.10 35 26 9 3.5 (1.5–8.2); P ¼ 0.004
Definition of abbreviations: a-gal ¼ galactose-a-1,3-galactose; ED ¼ emergency department.
All subjects with IgE titers greater than 0.35 are included in the .0.35 group.
All values greater than 3.5 are in the .3.5 group.
Odds ratio (95% confidence interval) is that for asthma compared with control subjects.
Figure 4. The meaning of a positive IgE antibody assay to cat epithelium varies by geographic location. (A and C) In northern Sweden, IgE to cat
epithelium is tightly correlated with having IgE antibodies to Fel d 1, not galactose-a-1,3-galactose(a-gal). (B and D) The opposite is true in rural
Kenya, where IgE to cat epithelium is correlated with having IgE antibodies to a-gal, not Fel d 1.
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in the southeastern United States (18). This is an example of
a parasite-induced IgE response that is common in a devel-
oped country. In contrast, we cannot make a convincing case
about the cause of IgE responses to a-gal in Africa where
children are exposed to many different parasites, including
nematodes, cestodes, and a range of ectoparasites including
ticks (13, 42). Previous studies have demonstrated that
specific IgE antibodies that are pertinent to asthma can be
correlated with total serum IgE (12, 43); here we have docu-
mented a specific IgE antibody response that is quantitatively
related to total serum IgE, but not associated with asthma.
Asthma is a heterogeneous disease state with multiple known
factors influencing its development. Similarly, total serum IgE
is now recognized to vary among individuals based on genet-
ics alone (44). Our findings, taken together with those of
genetic studies, suggest that consideration of specific sensiti-
zations is more pertinent to understanding risk for asthma
than is total serum IgE.
The results for the 18 year olds in Sweden provide a negative
control for the effects of helminths or ticks, because these para-
sites are very rare in the inland area of Norrbotten. In addition,
those results emphasize that IgE antibody responses to a-gal are
not induced by the oral route (e.g., eating red meat) or by any
other form of contact with a domestic animal (e.g., living in
a house with a cat). Thus, the Swedish data emphasize the im-
portance of the form and route of exposure. In Virginia, this
means exposure through the skin to the salivary proteins of an
arthropod.
The primary objective of this report was to investigate the
clinical relevance of IgE antibody responses to a-gal. How-
ever, the results address several related questions. First, it is
clear that presenting an antigen through the skin can induce
high-titer IgE antibody responses in humans and that these
responses can give rise to allergic symptoms after exposure
by a different route (oral exposure to red meat, in this case).
Second, the results provide a model for parasite-related IgE
responses that can contribute to high serum IgE without hav-
ing an effect on respiratory allergic symptoms. Third, within
the present and other recent studies, there is a consistent re-
lationship between the titer of IgE antibodies to inhalant aller-
gens and the risk of asthma (12, 43). These findings clearly do
not exclude the possibility of a noninhaled antigen associating
with asthma. The observations that a-gal is not airborne and
having IgE antibodies to a-gal does not increase the risk for
asthma, supports the view that those allergens most relevant to
asthma pathogenesis are those that are inhaled.
Author disclosures are available with the text of this article at www.atsjournals.org.
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